Drugs / Diphtheria, Tetanus and Acellular pertussis (Component) Combined Vaccine (Adsorbed)
Diphtheria, Tetanus and Acellular pertussis (Component) Combined Vaccine (Adsorbed)
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06817187 | Sep 2021 → Mar 2024 | pneumococcal infection | Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Diphtheria, Tetanus and Acellular pertussis (Component) Combined Vaccine (Adsorbed) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06817187 ↗ |
| Modality | Vaccine | “Diphtheria, Tetanus and Acellular pertussis (Component) Combined Vaccine (Adsorbed)” NCT06817187 ↗ |